Psychosexual Consequences of Risk-reducing Salpingo-oophorectomy
NCT02372864 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66
Last updated 2017-10-26
Summary
Short Rationale: Risk-reducing salpingo-oophorectomy (RRSO) is a mainstay in preventing ovarian cancer in BRCA1/2 mutation carriers, as ovarian cancer screening is ineffective in detecting ovarian cancer in an early and curable stage. Women who underwent RRSO experienced bothersome menopausal symptoms and worsening of sexual functioning related to acute surgical menopause. Hormone replacement therapy (HRT) will mitigate some of the RRSO induced menopausal complaints, however it does not reduce the complaints to a premenopausal level and the sexual symptoms are not alleviated. Mindfulness interventions were found to improve sexual functioning and alleviate menopausal symptoms in various populations. It has not been investigated whether mindfulness-based stress reduction (MBSR) is effective in mitigating the RRSO-induced menopausal complaints in BRCA1/2 mutation carriers and if this effect is sustained over a longer period of time.
Objective: To examine the effect of MBSR training on the menopause-specific quality of life in BRCA1/2 mutation carriers who experience RRSO-induced menopausal complaints.
Study population: Female BRCA1/2 mutation carriers who were younger than 52 years at the time of RRSO reporting two or more moderate to severe menopause related complaints after undergoing RRSO.
Study design: Prospective randomized controlled trial with a follow-up time of twelve months conducted at the University Medical Center Groningen (UMCG)
Intervention: Eight-week MBSR training consisting of a weekly class of two and half hours and a full retreat day. Furthermore participants are asked to practice mindfulness exercises at home for 45 minutes, six days a week.
Main study parameters/endpoints: Menopause specific quality of life score measured by the Menopause-specific quality of life questionnaire (MENQOL). Nature and extent of the burden and risks associated with participation, benefit and group relatedness: There are no risks associated with taking part in a MBSR training or filling out the questionnaires that will be used in this study. The content of the questionnaires concerns intimate matters and could be considered burdensome. A possible benefit for the participants of the MBSR training is that participants will be more able to cope with their complaints after RRSO. The group relatedness is reflected in the fact that RRSO is specifically performed in women with a hereditary risk of ovarian cancer such as BRCA1/2 mutation carriers.
Conditions
Interventions
- BEHAVIORAL
-
Mindfulness based stress reduction (MBSR)
Mindfulness based stress reduction (MBSR) is a standardized eight-week psychosocial intervention delivered by certified trainers. The programme consists of a weekly class of two and half hours for a period of eight weeks and a full retreat day. Furthermore participants are asked to practice exercises at home for 45 minutes, six days a week. The MBSR class will consist of ten to twelve persons, starting at different weekdays and moments of the day. If during the inclusion process it becomes apparent that a group of participants (provided a sufficient group size) comes from a region (e.g. Friesland or Overijssel) with a considerable amount of traveling time to the UMCG, efforts will be made to start a MBSR training in the region with trainers from the UMCG.
Sponsors & Collaborators
-
University Medical Center Groningen
lead OTHER
Principal Investigators
-
Marian JE Mourits, prof. dr. · University Medical Center Groningen
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-02-28
- Primary Completion
- 2016-12-31
- Completion
- 2016-12-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Does Menopause Matter?
NCT00097994 ·Status: COMPLETED
-
Changes to Vulva, Vestibule, Urethral Meatus and Vagina 20 Weeks Post Daily Prasterone in Women With Dyspareunia
NCT03568604 ·Status: COMPLETED ·Phase: PHASE4
-
A Longitudinal Study to Identify Mechanisms of Menopause on Cardiovascular Disease Risk
NCT05647876 ·Status: RECRUITING
-
Nursing Interventions to Enhance Positive Mental Health and Self Care in Women During the Climacteric
NCT07165964 ·Status: RECRUITING ·Phase: NA
-
Bioidentical 'Natural' Hormone Evaluation in Early Menopause
NCT00302731 ·Status: TERMINATED ·Phase: PHASE2
-
Non-ablative Diode Laser Therapy for Genitourinary Syndrome of Menopause: A Prospective Study on Efficacy, Safety, and Quality of Life and Sexuality Impact
NCT06503003 ·Status: RECRUITING
-
Effectiveness of a Telerehabilitation Program for Improving Sexual Function and Reducing Pain in Menopausal Women
NCT06710002 ·Status: RECRUITING ·Phase: NA
-
Primary Ovarian Insufficiency: Phenotype and Optimal Treatment
NCT03568708 ·Status: COMPLETED ·Phase: PHASE3
-
Brain Health in Breast Cancer Survivors
NCT04297020 ·Status: RECRUITING
-
GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors
NCT03185169 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
PRP Injections for Genitourinary Syndrome of Menopause
NCT06028009 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
NCT06975111 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Disentangling the Effects of Daily Stress, Sleep, and Sex Hormones on Accelerated Vascular Aging in Midlife Women
NCT06745466 ·Status: RECRUITING ·Phase: PHASE4
-
Polyphenols and Probiotics to Improve Menopausal Symptoms Via the Gut-Brain Axis
NCT06333223 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women
NCT03854396 ·Status: WITHDRAWN ·Phase: PHASE3
-
Hormone Replacement in Menopausal Women With Epilepsy
NCT00027209 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized-Controlled Trial to Examine the Effects of a Daily Probiotic Supplement on Common Symptoms of Menopause
NCT06148714 ·Status: COMPLETED ·Phase: NA
-
Photobiomodulation in Post Menopause Genitourinary Syndrome
NCT05557799 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Sex Steroid Hormones and Risk of CHD in Women
NCT00006407 ·Status: COMPLETED
-
Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer
NCT00079248 ·Status: UNKNOWN ·Phase: NA
-
The Menopause After Cancer Study
NCT04766229 ·Status: COMPLETED ·Phase: PHASE2
-
Therapy to Prevent Sexual Pain in Breast Cancer Survivors
NCT01539317 ·Status: COMPLETED ·Phase: PHASE3
-
Perception and Attitude Toward Estrogen Therapy Among Surgically Menopausal Women
NCT00173550 ·Status: UNKNOWN
-
Use of the Synthetic Hormone CDB-2914 in Treating Symptoms of Menopause
NCT00009659 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Ospemifene on Pelvic Vascularity and Blood Flow
NCT02010580 ·Status: WITHDRAWN